Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Halfvarson

Showing results (161-170 of 244) with videos related to

Pageof 25
Sort By:
Nature Microbiology|February 14, 2017
Dynamics of the human gut microbiome in inflammatory bowel diseaseJonas Halfvarson, Colin J Brislawn, Regina Lamendella, et al.
Ebiomedicine|November 13, 2024
Exposure to air pollution increases susceptibility to ulcerative colitis through epigenetic alterations in CXCR2 and MHC class III regionJie Chen, Han Zhang, Tian Fu, et al.
Gastroenterology|July 23, 2021
Systemic Inflammation in Preclinical Ulcerative ColitisDaniel Bergemalm, Erik Andersson, Johan Hultdin, et al.
Journal of Crohn'S & Colitis|February 25, 2022
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2Jan K Nowak, Alex T Adams, Rahul Kalla, et al.
Journal of Crohn'S & Colitis|August 16, 2023
Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus RecommendationsStefan Schreiber, Silvio Danese, Axel Dignass, et al.
Journal of Clinical Medicine|October 14, 2023
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi ConsensusFerdinando D'Amico, Virginia Solitano, Fernando Magro, et al.
Scandinavian Journal of Gastroenterology|April 1, 2017
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)Carl Eriksson, Jan Marsal, Daniel Bergemalm, et al.
Plos One|December 5, 2012
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's diseaseAlison R Erickson, Brandi L Cantarel, Regina Lamendella, et al.
The American Journal of Gastroenterology|December 1, 2007
Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and predictionPeggy Vandewalle-El Khoury, Jean-Frederic Colombel, Sofie Joossens, et al.
BMJ Open|May 16, 2024
Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT)Anja Fejrskov, Johannes David Füchtbauer, Lóa G Davíðsdóttir, et al.
Pageof 25

Showing results (161-170 of 244) with videos related to

Sort By:
Pageof 25
Nature Microbiology|February 14, 2017
Dynamics of the human gut microbiome in inflammatory bowel diseaseJonas Halfvarson, Colin J Brislawn, Regina Lamendella, et al.
Ebiomedicine|November 13, 2024
Exposure to air pollution increases susceptibility to ulcerative colitis through epigenetic alterations in CXCR2 and MHC class III regionJie Chen, Han Zhang, Tian Fu, et al.
Gastroenterology|July 23, 2021
Systemic Inflammation in Preclinical Ulcerative ColitisDaniel Bergemalm, Erik Andersson, Johan Hultdin, et al.
Journal of Crohn'S & Colitis|February 25, 2022
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2Jan K Nowak, Alex T Adams, Rahul Kalla, et al.
Journal of Crohn'S & Colitis|August 16, 2023
Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus RecommendationsStefan Schreiber, Silvio Danese, Axel Dignass, et al.
Journal of Clinical Medicine|October 14, 2023
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi ConsensusFerdinando D'Amico, Virginia Solitano, Fernando Magro, et al.
Scandinavian Journal of Gastroenterology|April 1, 2017
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)Carl Eriksson, Jan Marsal, Daniel Bergemalm, et al.
Plos One|December 5, 2012
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's diseaseAlison R Erickson, Brandi L Cantarel, Regina Lamendella, et al.
The American Journal of Gastroenterology|December 1, 2007
Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and predictionPeggy Vandewalle-El Khoury, Jean-Frederic Colombel, Sofie Joossens, et al.
BMJ Open|May 16, 2024
Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT)Anja Fejrskov, Johannes David Füchtbauer, Lóa G Davíðsdóttir, et al.
Pageof 25